By Aaron Leibowitz ( November 13, 2018, 7:09 PM EST) -- Defendant David Johnston took the witness stand Tuesday in Boston federal court and told jurors the government was correct that his former company, Aveo Pharmaceuticals Inc., chose not to tell investors about the U.S. Food and Drug Administration's recommendation for a new clinical trial for its flagship kidney cancer drug, Tivo....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.